LSA
HRMY icon

Leonteq Securities AG’s Harmony Biosciences HRMY Stock Holding History

Leonteq Securities AG’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.1K Hold
800
– – ﹤0.01% 909
2026
Q1 		$22.4K Hold
800
– – ﹤0.01% 978
2025
Q4 		$29.9K Buy
800
+200
+33% +$6.58K ﹤0.01% 1037
2025
Q3 		$16.5K Buy
600
+200
+50% +$6.89K ﹤0.01% 1061
2025
Q2 		$12.6K Hold
400
– – ﹤0.01% 1035
2025
Q1 		$13.3K Hold
400
– – ﹤0.01% 1022
2024
Q4 		$13.8K Sell
400
-400
-50% -$13.7K ﹤0.01% 1016
2024
Q3 		$32K Hold
800
– – ﹤0.01% 842
2024
Q2 		$24.1K Buy
+800
New +$24.1K ﹤0.01% 898
2023
Q3 		– Sell
-2,295
Closed -$80.8K – 1242
2023
Q2 		$80.8K Buy
2,295
+1,925
+520% +$66.5K ﹤0.01% 729
2023
Q1 		$12.1K Hold
370
– – ﹤0.01% 990
2022
Q4 		$20.4K Hold
370
– – ﹤0.01% 966
2022
Q3 		$16.4K Hold
370
– – ﹤0.01% 982
2022
Q2 		$18K Hold
370
– – ﹤0.01% 992
2022
Q1 		$18K Hold
370
– – ﹤0.01% 1018
2021
Q4 		$15.8K Buy
+370
New +$14.7K ﹤0.01% 1098

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Leonteq Securities AG's HRMY Position: Q2 2026 in Review

Leonteq Securities AG held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 800 shares worth $29.1K. The position accounts for ﹤0.01% of the portfolio, ranked #909.

Leonteq Securities AG first reported a position in HRMY in Q4 2021 and has held it in 16 quarters since. The position peaked at $80.8K in Q2 2023. 326 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Leonteq Securities AG held 800 shares of Harmony Biosciences worth $29.1K as of Q2 2026.
  • Leonteq Securities AG left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #909 holding.
  • Leonteq Securities AG first reported a position in Harmony Biosciences in Q4 2021 and has held it in 16 quarters since.
  • Leonteq Securities AG's Harmony Biosciences position peaked at $80.8K in Q2 2023.
  • 326 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.